Short CV/Education and training

  • PhD from the University of Edinburgh. Lecturer and Senior Lecturer at Imperial College until 2001.

  • Ten years in senior scientific roles in the UK biotech sector followed by three years at Pfizer.

  • Currently International Director for PraxisUnico, the UK network that supports professionals working in knowledge exchange and commercialisation. Served on a number of committees for UK research councils and is a Visiting Professor at Imperial College. Passionate about public engagement and the author of two popular science books, "The Epigenetics Revolution" and "Junk DNA".

Selected publications

  • Carey N, Marques CJ, Reik W. DNA demethylases: a new epigenetic frontier in drug discovery. Drug Discov Today. 2011 Aug;16(15-16): 683-90.

  • Best JD, Carey N. Epigenetic therapies for non-oncology indications. Drug Discov Today. 2010 Dec;15(23-24): 1008-14.

  • Best JD, Carey N. Epigenetic opportunities and challenges in cancer. Drug Discov Today. 2010 Jan;15(1-2): 65-70.

  • Flanagan JM, Funes JM, Henderson S, Wild L, Carey N, Boshoff C. Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets. Mol Cancer Ther. 2009 Jan;8(1): 249-60.

  • Carey N, La Thangue NB. Histone deacetylase inhibitors: gathering pace. Curr Opin Pharmacol. 2006 Aug;6(4): 369-75. Epub 2006 Jun 14.

  • Sadusky TJ, Kemp TJ, Simon M, Carey N, Coulton GR. Identification of Serhl, a new member of the serine hydrolase family induced by passive stretch of skeletal muscle in vivo. Genomics. 2001 Apr 1;73(1): 38-49.

  • Eriksson M, Ansved T, Edstrom L, Wells DJ, Watt DJ, Anvret M, Carey N. Independent regulation of the myotonic dystrophy 1 locus genes postnatally and during adult skeletal muscle regeneration. J Biol Chem. 2000 Jun 30;275(26): 19964-9.

  • Eriksson M, Ansved T, Edström L, Anvret M, Carey N. Simultaneous analysis of expression of the three myotonic dystrophy locus genes in adult skeletal muscle samples: the CTG expansion correlates inversely with DMPK and 59 expression levels, but not DMAHP levels. Hum Mol Genet. 1999 Jun;8(6): 1053-60. PubMed PMID: 10332037.

Selected projects

  • Drug discovery in epigenetics

  • Analyses of pathological pathways in myotonic dystrophy

Membership in scientific bodies/juries

  • Member of BBSRC Biosciences for Industry panel, since 2011

  • Member of MRC Molecular and Cellular Medicine Board, since 2011

Media coverage

  • Interviewed 3 times on Radio 4 Today programme, talking about epigenetics: Epigenetics – The key to cancer?

  • Talked about epigenetics for the BBC World Service

  • Popular science article in BBC Focus magazine: Deadly Mega Erruption

  • Multiple public engagement events including: Edinburgh Science Festival; Edinburgh International Book Festival;Cheltenham Science Festival; British Science Festival; Royal Society Summer Science exhibition; U3A at the Royal Institution

  • Blogs for The Huffington Post: Entry on

Additional qualifications

  • Registered Technology Transfer Professional (RTTP)

Soft Skills/Other activities and achievements

Soft Skills

  • Public speaking

  • Supporting younger scientists

  • Accessible scientific writing

Other activities and achievements/family

  • Other activities and interests: Women in science, Enthusing children and young adults about science, Translational science, Scientific career paths, Media


You can only see the contact information of the academics in the database if you are a registered user of AcademiaNet.
Please register here


  1. Read what our members say about AcademiaNet.

Follow us

Similar profiles

  1. Prof. Patrizia Agostinis

    Biological and related sciences, Health, Cell Biology, Cellular signaling, Cancer biology, Cancer therapy

  2. Dr. Irene Agyepong

    Health, Public Health

  3. Prof. Anne Angelillo-Scherrer

    Biological and related sciences, Health, Hematology, Internal Medicine; Special focus: hemostasis and thrombosis, laboratory diagnosis particularly in the field of hemostasis and thrombosis, myeloproliferative neoplasms and their bleeding/thrombotic complications

  4. Prof. Dr. Heike Allgayer

    Biological and related sciences, Health

Academia Net